You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

näive

Showing 1 - 25 of 5,647
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Twin Vaginal Delivery Skills Trial in Pescara (twin vaginal delivery simulation)

Recruiting
  • Twin Vaginal Delivery Skills
  • twin vaginal delivery simulation
  • Pescara, Italia, Italy
    Claudio Celentano
Nov 6, 2023

Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)

Not yet recruiting
  • Vitamin D Deficiency
  • Peripheral Neuropathy
  • Vitamin D
  • (no location specified)
May 2, 2023

Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))

Active, not recruiting
  • Prostate Cancer
  • Multiparametric magnetic resonance imaging (mpMRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Advanced Solid Tumor Trial (INCB099280)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 19, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Atrial

Recruiting
  • Atrial Fibrillation
  • AI-enabled ECG score for Atrial Fibrillation (DNN score)
  • Atrial voltage map in sinus rhythm
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Oct 19, 2023

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

GHD Trial in Fort Worth (GenSci004, Genotropin)

Not yet recruiting
  • GHD
  • Fort Worth, Texas
    Cook Childrens
Aug 24, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab Vedotin, Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023

Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab, Etoposide, Cisplatin or Carboplatin
  • Milano, Italy
  • +2 more
Oct 10, 2023

Schizophrenia Trial in Changsha (transcranial magnetic stimulation, sham stimulation)

Active, not recruiting
  • Schizophrenia
  • transcranial magnetic stimulation
  • sham stimulation
  • Changsha, Hunan, China
    Central South University
Nov 16, 2022

HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))

Not yet recruiting
  • HIV-1-infection
  • Low-dose STP0404 (Pirmitegravir)
  • +3 more
  • (no location specified)
May 16, 2023

IBD Trial in Paris (Biocollection)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biocollection
  • Paris, France
    Saint Antoine Hospital Service de Gastroentérologie et Nutrition
Feb 1, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

HIV Positive Trial in Saint-etienne (blood and urinary samples)

Not yet recruiting
  • HIV Positive
  • blood and urinary samples
  • Saint-etienne, France
    Chu Saint-Etienne
Nov 29, 2022

Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept

Not yet recruiting
  • Diabetic Macular Edema
  • +2 more
  • Vitrectomy combined with ILM peeling
  • Conbercept intravitreal injection
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Feb 14, 2023

Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Ustekinumab Among Bio-naive Crohn's Disease in China

Not yet recruiting
  • Crohn Disease
  • Hangzhou, Zhejiang, China
  • +2 more
Oct 9, 2023

Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)

Not yet recruiting
  • Malaria
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 28, 2023

Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))

Completed
  • Healthy Volunteers
  • INO-A002
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 7, 2022

The First Affiliated Hospital of Nanchang University Trial in Nanchang, Jinan (Orelabrutinib+R-CHOP)

Recruiting
  • The First Affiliated Hospital of Nanchang University
  • Nanchang, Jiangxi, China
  • +1 more
Jul 3, 2023

Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • Anti-C5 antibody treatment
  • Paris, France
    AP-HP Hôpital Saint Louis
Apr 24, 2023

Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)

Completed
Has Results
  • Helicobacter Pylori Infection
  • New York, New York
    Mount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023